ARCHIVES

Fallout Over PSA Guidance Continues—Specialty Groups Dissent, Congress Attacks

This article is from The Cancer Letter archive.

Vol. 38 No. 29 | July 20, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Proposal Would Give Drug Sponsors Commercial Rights To Biomarker Inventions

October 16, 2009

Gene Therapy Shows Positive Results In Phase III Trial

July 25, 2008

Judge Invalidates Bristol-Myers’ Claims For The Administration Of Taxol.

March 3, 2000

Capizzi Succeeds Spurr as Director Of Bowman Gray Cancer Center

September 10, 1982

Economic Analyses Of New Therapies Useful In Phase III Studies, Trialists Say

July 24, 2009

FDA Can’t Prohibit Distribution of Articles, Books On Off-Label Drug Use, Judge Rules

August 13, 1999